Related Experiment Video
Updated: Jul 5, 2025

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Pleural fluid soluble Fas ligand and tuberculous pleural effusion: a prospective diagnostic test accuracy study
Xu-Hui Wen1,2, Jian-Xun Wen3, Lan Mu1
1Department of Parasitology, The Basic Medical Sciences College of Inner Mongolia Medical University, Hohhot, China.
Background:
The diagnosis of tuberculous pleural effusion (TPE) is challenging for pulmonologists. Adenosine deaminase (ADA), interferon-gamma (IFN-γ), and interleukin-27 (IL-27) have some limitations for diagnosing TPE. Soluble Fas ligand (sFasL) had a high diagnostic value for TPE. However, it remains unknown: (I) whether sFasL has an additional diagnostic value to the traditional markers (e.g., ADA); (II) whether sFasL provides a net benefit in patients with undiagnosed pleural effusion; (III) factors affecting the diagnostic accuracy of sFasL for TPE. This study aimed to evaluate the additional diagnostic value and benefit of pleural fluid sFasL for TPE.
Methods:
We prospectively enrolled 211 patients with undiagnosed pleural effusion. The concentration of sFasL in pleural fluid was measured by an enzyme-linked immunosorbent assay (ELISA). The diagnostic accuracy and net benefit of sFasL and ADA for TPE were analyzed by a receiver operating characteristic (ROC) curve, decision curve analysis (DCA), net reclassification improvement (NRI), and integrated discriminant improvement (IDI).
Results:
The area under the ROC curves (AUCs) of sFasL and ADA were 0.74 (95% CI: 0.65-0.83) and 0.80 (95% CI: 0.71-0.90), respectively. The decision curve of sFasL revealed net benefit. The continuous NRI and IDI of sFasL were 0.36 (0.00-0.72, P=0.05) and 0.02 (-0.01-0.06, P=0.18), respectively.
Conclusions:
Pleural fluid sFasL has moderate diagnostic accuracy for TPE.
Insights
Soluble Fas ligand (sFasL) shows moderate diagnostic accuracy for tuberculous pleural effusion (TPE). While not superior to adenosine deaminase (ADA), sFasL offers a net benefit in diagnosing TPE in patients with undiagnosed pleural effusion.
Area of Science:
- Pulmonology
- Infectious Diseases
- Biomarker Research
Background:
- Tuberculous pleural effusion (TPE) diagnosis is challenging.
- Traditional markers like adenosine deaminase (ADA) have limitations.
- Soluble Fas ligand (sFasL) shows potential for TPE diagnosis.
Purpose of the Study:
- Evaluate the additional diagnostic value of pleural fluid sFasL for TPE.
- Assess the net benefit of sFasL in diagnosing TPE.
- Investigate factors influencing sFasL diagnostic accuracy.
Main Methods:
- Prospective enrollment of 211 patients with undiagnosed pleural effusion.
- Measurement of pleural fluid sFasL concentration using ELISA.
- Analysis of diagnostic accuracy and net benefit using ROC curves, DCA, NRI, and IDI.
Main Results:
- sFasL demonstrated moderate diagnostic accuracy (AUC=0.74) for TPE.
- ADA showed higher accuracy (AUC=0.80).
- sFasL analysis indicated a net benefit and significant improvement in reclassification (NRI=0.36, P=0.05).
Conclusions:
- Pleural fluid sFasL has moderate diagnostic accuracy for TPE.
- sFasL provides a net benefit in diagnosing TPE.
- sFasL may complement traditional markers like ADA for TPE diagnosis.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

